About Keith Loebner
Keith Loebner is a director at Integrated Biosciences.
Form D filings also name Keith Loebner as a managing director at sutter hill ventures at Fathom Therapeutics.
Experience
This experience comes from Keith Loebner's profile and from SEC filings. For roles taken from filings, the years are when the filings name Keith Loebner in the role, so the role may have started earlier or lasted longer.
RB
Ridge Bio Current
Board Member
2025 – Present
Atommap Corp Current
Managing Director at Sutter Hill Ventures
2023 – Present · New York, NY
Designs potential medicines using AI and simulations of molecules inside cells.
II
Inograft Biotherapeutics, Inc. Current
Board Member
2023 – Present
SB
Savanna Bio Current
Board Member
2022 – Present
SV
Sutter Hill Ventures Current
Managing Director
2019 – Present
LC
Luminary Cloud
Board Observer
2022 – 2025
SG
Schox Patent Group
Senior Associate | Patent Agent
2015 – 2019
SU
Stanford University
Graduate Researcher, Ph.D. Candidate
2011 – 2017
SP
Stanford Technology Ventures Program (STVP) -- Accel Leadership Program
Accel Fellow
2014 – 2015
NS
Naval Postgraduate School
Naval Research Enterprise Intern
2013
LL
Lawrence Livermore National Laboratory
High Energy Density Physics Intern
2012
Key Colleagues at Startups
The people Keith Loebner works with at each company, as listed on that company's latest Form D.
Integrated Biosciences, Inc. · Form D, Aug 5, 2026
TK
Themasap Khan
Director
FW
Felix Wong
Chief Executive Officer and director
Atommap Corp · Form D, Mar 20, 2026
HX
Huafeng Xu
Co-Founder and CEO, director